OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Top 3 AI Stocks to Invest in Right Now

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds • News

BioNTech and Pfizer’s COVID-19 vaccine is surprisingly effective, though experts question what effectiveness will look like in the real world

November 13, 2020

BioNTech and Pfizer Inc.’s unexpectedly efficacious COVID-19 vaccine candidate caught Wall Street and the medical community by surprise this week, yet the same...

3rdPartyFeeds • News

TaxWatch: ‘I think everybody’s taken a deep breath’: Joe Biden didn’t get a ‘blue wave’ but here are 5 ways he can advance his tax agenda

November 13, 2020

With two Senate seats up for grabs, what does this mean for families thinking about their tax bill in a Biden era?

Read More...

3rdPartyFeeds

Disney Stock Is Climbing After Earnings. Here’s What Wall Street Is Saying.

November 13, 2020

Disney stock (ticker: DIS) is down less than 5% in 2020—at a recent $138, up 2% Friday—despite swinging to a loss in at least two quarters when it had been...

3rdPartyFeeds

Cronos Group Inc. to Present at the Jefferies Virtual West Coast Consumer Conference

November 13, 2020

TORONTO, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid...

3rdPartyFeeds

5 Chip Stocks With Stellar Prospects

November 13, 2020

Chip demand is surging, even as mergers reshape the industry. Evercore ISI analyst C.J. Muse explains how to play the next growth spurt—and why stocks like...

3rdPartyFeeds

Disney Stock Gets Wall Street Love As Analysts Lift Price Targets On Streaming Upside

November 13, 2020

A number of Wall Street analysts have increased their price targets for Disney's stock after the media giant reported better-than-expected quarterly earnings...

3rdPartyFeeds

FTC chairman warns of antitrust threat as Facebook braces for action

November 13, 2020

In a speech that could foreshadow antitrust action against Facebook, Federal Trade Commission Chairman Joe Simons warned Thursday that antitrust regulators...

3rdPartyFeeds

Disney misses earnings estimates, posts $2.8B annual loss

November 13, 2020

Vontobel Asset Management Portfolio Manager Markus Hansen joins Yahoo Finance Live to break down Disney’s fourth-quarter earnings report and the latest...

3rdPartyFeeds

NXST vs. NFLX: Which Stock Should Value Investors Buy Now?

November 13, 2020

NXST vs. NFLX: Which Stock Is the Better Value Option? Read More...

3rdPartyFeeds • News

: Here are 5 things to know about BioNTech and the married couple developing the COVID-19 vaccine with Pfizer

November 13, 2020

Co-founded by Turkish scientists Uğur Şahin and his wife Özlem Türeci, BioNTech is now worth $25 billion.

Read More...

Previous 1 … 5,342 5,343 5,344 5,345 5,346 … 8,455 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.